AnVIL
NHGRI Analysis Visualizationand Informatics Lab-space
searchclose
TwitterYouYubeDiscourseGitHubSlack

Study

arrow_backDatasets

NHLBI TOPMed - NHGRI CCDG: AFLMU

CCDGphs001543.v1.p1dbGapdbGap FHIR

Description

The Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study contributes to the spectrum of disease by adding carefully characterized patients with atrial fibrillation. Atrial fibrillation, one of the most common human arrhythmias confers major morbidity, mortality and health care cost, and has been demonstrated to be caused and influenced by genetic and -omics factors. Particularly, AFLMU enrolled patients with an early onset of atrial fibrillation to increase the genetic burden on disease pathophysiology. All patients were recruited applying standardized protocols to maintain homogeneity in data and DNA quality.

Stats

1Cohorts
248Samples
248Participants
5.37 TBSize

Summary

Consent Codesnot applicable
Diseasesatrial fibrillation
AccessConsortium Access
Study DesignCase Set
Data TypesWhole Genome

Terra Workspaces

This study has been divided into the following workspaces by consent codes and optionally the originating laboratory.

Terra Workspace NameConsent CodeDiseaseAccessStudy DesignData TypeSamplesParticipantsSize (TB)
AnVIL_CCDG_Broad_CVD_AFib_AFLMU_WGSnot applicableatrial fibrillationCase SetWhole Genome2482485.37